Investigations
-
Where have all the Long COVID clinics gone?
A nationwide survey reveals the uncertain state of specialized care for Americans living with the chronic disease
-
Metrodora promised comprehensive treatment. But within two years, it abruptly closed.
The clinic sought to cure “neuroimmune disorders” like Long COVID and myalgic encephalomyelitis. Former patients feel betrayed.
-
Less than 20% of Long COVID trials involving exercise even mention post-exertional malaise
An analysis by The Sick Times find that less than 15% of Long COVID clinical trials testing the benefits of exercise or cardiopulmonary rehabilitation measured post-exertional malaise, according to their trial registration, while a handful excluded participants who experience it.
-
Germany’s “Reha” clinics aren’t set up for Long COVID. And patients are reporting harm.
The country’s pension insurance system pushes people to go through rehabilitation (“Reha”) clinics before they can access disability supports.
-
Berlin Cures’ failed Long COVID clinical trial yields lessons on study design
After advertising a potential Long COVID “cure” in its novel drug, called BC 007 (rovunaptabin), the German start-up Berlin Cures abruptly concluded its phase II clinical trial with a brief press release in November 2024 announcing the study was unsuccessful. The Sick Times spoke with study participants and outside experts and found that, while some…
-
Experts call new Canadian Long COVID guidelines “contradictory” and “deeply concerning”
Guidelines recommend exercise and therapy as treatments, following attempted influence from Paul Garner.
-
Priced out: Some Long COVID and ME specialists charge high prices for concierge care
One specialist is charging up to $8,500 a month. But the providers say insurance companies are to blame. Key points you should know: Rachel Graves knows of exactly two neurologists specializing in dysautonomia in Washington state. In addition to dysautonomia, Graves, who lives in Tacoma, has been diagnosed with numerous conditions, including hypermobile Ehlers–Danlos syndrome…
-
With no approved treatments and little support, people with Long COVID turn to online drug markets
With no approved treatments, lack of support, and stigma against the disease, many people with Long COVID are using overseas pharmacies to source medications. Some of these treatments are widely used for other conditions, such as HIV and hepatitis C, but are not approved for use in Long COVID.
-
Frustrations, denials, long drives: Immunocompromised people can’t access a lifesaving Covid-19 drug
A new drug approved months ago to help prevent Covid-19 infections could be a game changer for high-risk people — if they can get their hands on it. But many say they have struggled to access the medication.
-
‘They bungled it:’ NIH documents reveal how $1.6 billion Long Covid initiative has failed so far to meet its goals
In February 2021, the National Institutes of Health launched a new $1 billion initiative to study Long Covid, a chronic disease that has changed the lives of millions of Americans. Three years later, the NIH initiative, called RECOVER, has not met these goals, according to a detailed review of budget and planning documents obtained through…
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
A new aid in the doctor’s office: Introducing the Long COVID Treatment Guide
-
Where have all the Long COVID clinics gone?
-
National COVID-19 trends, March 10
-
Research updates, March 10
-
My child and I both have Long COVID. Even in COVID-aware spaces, we are excluded because of their pre-existing disability.
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance